CN Patent
CN115947758A — 一种核苷酸衍生物及其药物组合物和用途
Assigned to Nanjing Zhihe Medical Technology Co ltd · Expires 2023-04-11 · 3y expired
What this patent protects
本发明公开了一种核苷酸衍生物及其药物组合物和用途,所述核苷酸衍生物如式(I)所示,其中各基团的定义详见说明书;该化合物可用于抗病毒感染。
USPTO Abstract
本发明公开了一种核苷酸衍生物及其药物组合物和用途,所述核苷酸衍生物如式(I)所示,其中各基团的定义详见说明书;该化合物可用于抗病毒感染。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.